Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS) is a devastating hypoxemic respiratory failure, characterized by disruption of the alveolar-capillary membrane barrier. Current management for ARDS remains supportive, including lung-protective ventilation and a conservative fluid strategy. Mesenchymal stem...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jibin, Liu, Yuxiang, Liu, Hong, Li, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915956/
https://www.ncbi.nlm.nih.gov/pubmed/31843004
http://dx.doi.org/10.1186/s13287-019-1518-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915956/
https://www.ncbi.nlm.nih.gov/pubmed/31843004
http://dx.doi.org/10.1186/s13287-019-1518-0

Ejemplares similares